LGND
Ligand Pharmaceuticals Incorporated
NASDAQ: LGND · HEALTHCARE · BIOTECHNOLOGY
$224.86
-3.21% today
Updated 2026-04-29
Market cap
$2.73B
P/E ratio
36.74
P/S ratio
10.17x
EPS (TTM)
$6.12
Dividend yield
—
52W range
$99 – $247
Volume
0.2M
Ligand Pharmaceuticals Incorporated (LGND) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $314.62M | $326.05M | $173.28M | $171.45M | $113.70M | $75.56M | $122.35M | $104.26M | $104.71M | $258.03M | $533.93M | $601.59M | $671.02M | $1.26B | $1.49B | $1.36B | $1.30B | $762.67M | $787.22M | $941.77M |
| Cash & equivalents | $66.76M | $158.40M | $76.81M | $28.75M | $16.03M | $3.35M | $7.04M | $12.38M | $15.98M | $167.34M | $200.22M | $141.05M | $201.66M | $718.38M | $71.54M | $47.62M | $19.52M | $45.01M | $22.95M | $72.31M |
| Current assets | $132.97M | $235.56M | $109.94M | $93.93M | $68.17M | $37.02M | $32.23M | $23.82M | $24.88M | $185.16M | $215.57M | $163.05M | $237.02M | $870.54M | $1.12B | $500.56M | $464.75M | $263.60M | $237.43M | $331.56M |
| Total liabilities | $425.04M | $298.70M | $144.16M | $181.81M | $109.95M | $82.55M | $113.70M | $77.78M | $55.10M | $233.62M | $229.54M | $230.73M | $252.37M | $699.89M | $727.68M | $652.76M | $476.43M | $165.18M | $86.30M | $111.33M |
| Current liabilities | $235.21M | $170.81M | $50.97M | $70.61M | $52.17M | $35.63M | $43.64M | $35.44M | $28.94M | $22.78M | $20.84M | $227.13M | $238.87M | $82.25M | $17.00M | $100.11M | $41.66M | $98.81M | $16.78M | $37.11M |
| Long-term debt | $170.18M | $2.16M | $627000.00 | $2.18M | — | — | $20.29M | $19.41M | $0.00 | $3.07M | $39.63M | $29.56M | $18.86M | $609.86M | $638.96M | $442.29M | $320.72M | — | — | — |
| Shareholder equity | $-110.42M | $27.35M | $29.11M | $-10.37M | $3.74M | $-6.99M | $8.65M | $26.48M | $49.61M | $26.32M | $304.39M | $370.85M | $418.65M | $560.91M | $767.23M | $709.52M | $821.16M | $597.49M | $700.91M | $830.44M |
| Retained earnings | $-831.06M | $-862.80M | $-581.51M | $-679.63M | $-681.57M | $-691.95M | $-681.77M | $-682.76M | $-671.34M | $-659.32M | $-402.01M | $-431.13M | $-400.92M | $-229.20M | $400.11M | $391.95M | $449.09M | $450.86M | $503.02M | $498.98M |
| Accounts receivable | $20.95M | $15.59M | $14.30M | $12.10M | $10.40M | $13.74M | $12.43M | $8.92M | $6.55M | $13.64M | $11.68M | $17.91M | $29.47M | $55.85M | $41.75M | $59.06M | $91.65M | $35.04M | $39.31M | $42.45M |
| Inventory | $9.33M | $3.86M | $-10.47M | $1.15M | $-53.23M | $-22.70M | $1.30M | $1.70M | $1.39M | $269000.00 | $1.63M | $1.92M | $4.37M | $7.12M | $7.30M | $26.49M | $27.33M | $13.29M | $23.97M | $14.11M |
| Goodwill | — | — | — | $5.38M | $700000.00 | $700000.00 | $14.89M | $68.15M | $65.34M | $62.96M | $60.59M | $276.91M | $314.54M | $306.44M | $95.23M | $189.66M | $105.67M | $105.67M | $103.37M | $105.25M |